Accueil   Diary - News   All news VALBIOTIS strengthens its Board of Directors with the appointment of Murielle CAZAUBIEL

VALBIOTIS strengthens its Board of Directors with the appointment of Murielle CAZAUBIEL

La Rochelle, February 4, 2019 (5:40 CET) – VALBIOTIS (FR0013254851 - ALVAL / eligible PEA/PME), a French research and development company committed to scientific innovation for preventing and combating metabolic diseases, today announced the expansion of its Board of Directors with the appointment of Murielle CAZAUBIEL, Director of Development and Medical Affairs at VALBIOTIS.



"Murielle CAZAUBIEL has managerial and entrepreneurial skills and experience that go beyond clinical development. Murielle’s appointment strengthens the Board, and her contributions will be essential in ensuring VALBIOTIS’s future growth trajectory", comments Sébastien PELTIER, CEO of VALBIOTIS

 

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree